PROTEIN DESIGN LABS INC/DE
S-3/A, EX-23.2, 2000-09-25
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PROTEIN DESIGN LABS INC/DE, S-3/A, EX-5.1, 2000-09-25
Next: FIRST TRUST COMBINED SERIES 151, 24F-2NT, 2000-09-25



<PAGE>   1

                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the captions "Selected Financial
Data" and "Experts" in Amendment No. 1 to the Registration Statement (Form S-3
No. 333-44754) and related Prospectus of Protein Design Labs, Inc. for the
registration of 3,450,000 shares of its common stock and to the incorporation by
reference therein of our report dated February 1, 2000 with respect to the
consolidated financial statements of Protein Design Labs, Inc. included in its
Annual Report on Form 10-K for the year needed December 31, 1999, filed with the
Securities and Exchange Commission.

                                                 /s/ ERNST & YOUNG LLP

Palo Alto, California
September 25, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission